Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Working Capital/Sales

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

GENPHARMASEC Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023
   Working Capital/Sales(x) 1.930.791.51

What is the latest Working Capital/Sales ratio of GENPHARMASEC ?

The latest Working Capital/Sales ratio of GENPHARMASEC is 1.93 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20251.93
Mar20240.79
Mar20231.51

How is Working Capital/Sales of GENPHARMASEC Trending?

Years Working Capital/Sales % Change
Mar2025 1.93
144.30
Mar2024 0.79
-47.68
Mar2023 1.51 -

Other Financial Ratios of GENPHARMASEC


Compare Working Capital/Sales ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹46.5 Cr -9.7% -37.3% -55.6% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹5,991.4 Cr -5.9% -14.2% -21.1% Stock Analytics
KIRI INDUSTRIES ₹2,103.2 Cr -6.6% -23.3% -38.4% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,325.8 Cr -5% -11.5% -38.1% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,002.2 Cr 3.7% 0.9% 7% Stock Analytics
BODAL CHEMICALS ₹719.3 Cr 5% 20.8% -10.9% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-9.7%

-37.3%

-55.6%

SENSEX

-0.8%

-11.7%

-3.6%


You may also like the below Video Courses